SBIR/STTR Research Award
MULTIPLEXED SENSITIVE TESTING FOR DRUGS OF ABUSE
Award amount
$99,989Program and phase
SBIR · Phase IAward year
2010Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- BIOMEDOMICS, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- PHS2010-1
- Topic code
- NIDA
Research abstract
Most drugs of abuse (DOA) testing is performed in a central lab that requires the shipping of specimens, expensive equipment (GC/MS/LS), long turnaround times, and uses valuable staff resources with current testing. Current DOA point of care (POC) assays used as pre-screening assays are generally not as sensitive or accurate as GC/MS/LS, and often times requires extra staff according to specific guidelines.
Technology keywords
Not reported
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Wearable Wireless Respiratory Monitoring System that Detects and Predicts Opioid Induced Respiratory Depression
- Building and testing the Life Enhancement and Advocacy Programming digital training tool (LEAPLink) to better serve people with lived experience of homelessness and substance use disorder
- A digital intervention to decrease self-stigma among pregnant and postpartum women with opioid use disorder
- Development of medication for the treatment of respiratory depression due to opioid (prescribed or illicit) overdose/multidrug (polysubstance) overdose in a hospital or community setting.
- Creation and Validation of the Dose-Opioid-Source Evaluation tool (DOSE) - a Robust Opioid Use Clinical Outcome Assessment for Qualification as an FDA Medical Device Development Tool (MDDT)